Month: November 2025
-
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
BOSTON, November 4, 2025 – Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the appointment of Marcel Reichen, Ph.D., MBA, as the company’s Chief Strategy Officer. Dr. Reichen brings over